Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
BMC Cancer|June 16, 2010
Characterization of AKT independent effects of the synthetic AKT inhibitors SH-5 and SH-6 using an integrated approach combining transcriptomic profiling and signaling pathway perturbationsTill Krech, Margarethe Thiede, Ellen Hilgenberg, et al.
Clinical Transplantation|July 26, 2019
Tissue inhibitor of metalloproteinase 1 and AST-to-Platelet Ratio Index as noninvasive biomarkers predict allograft fibrosis after pediatric liver transplantationJan Beime, Till Krech, Sandra Hischke, et al.
Cancer Letters|November 29, 2011
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cellsTill Krech, Elisa Scheuerer, Robert Geffers, et al.
Disease Markers|June 12, 2012
Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancerMaximilian Knoener, Till Krech, Florian Puls, et al.
Pediatrics|August 13, 2016
Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune HepatitisFlorian Brinkert, Philomena Arrenberg, Till Krech, et al.
Cancer Science|June 25, 2009
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancerMatthias Christgen, Henriette Christgen, Charlotte Heil, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
Virchows Archiv : an International Journal of Pathology|October 1, 2014
Frequency of TERT promoter mutations in primary tumors of the liverAlexander Quaas, Theresa Oldopp, Lars Tharun, et al.
The Journal of Biological Chemistry|December 31, 2009
Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cellsMatthias Christgen, Robert Geffers, Matthias Ballmaier, et al.
Scientific Reports|March 14, 2019
Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liverLaura Berkhout, Roja Barikbin, Birgit Schiller, et al.
Pageof 18